Design, synthesis, molecular dynamics and in silico pharmacokinetic study of N-(4-(thiazol-2-ylamino)phenyl)benzamide analogues as promising anti-inflammatory agents
Authors:
- Manoj KashyapManoj Kashyap
- Muslek Uddin MazumderMMMuslek Uddin Mazumder
- Pooja PatowaryPPPooja Patowary
- Lalnun HruaitluangiLHLalnun Hruaitluangi
- Lalzikpuii SailoLSLalzikpuii Sailo
- Babita DekaBDBabita Deka
- Debaprotim DasguptaDDDebaprotim Dasgupta
- Apurba TalukdarATApurba Talukdar
- Bhargab Jyoti SahariahBSBhargab Jyoti Sahariah
- 8 December 2025
- journal article
- research article
- Published by Springer Nature in Chemical Papers
- Vol. 80 (3) , 2627-2645
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Design, classification, and adverse effects of NSAIDs: A review on recent advancementsBioorganic & Medicinal Chemistry, 2024
- Design, synthesis, biological and computational screening of novel pyridine-based thiadiazole derivatives as prospective anti-inflammatory agentsHeliyon, 2024
- Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2/3 kinasesEuropean Journal of Medicinal Chemistry, 2023
- Coumarin linked thiazole derivatives as potential α-glucosidase inhibitors to treat diabetes mellitusMolecular Diversity, 2023
- Pharmacological evaluation of antinociceptive and anti-inflammatory activities of LQFM202: a new piperazine derivativeInflammopharmacology, 2022
- New tilomisole-based benzimidazothiazole derivatives as anti-inflammatory agents: Synthesis, in vivo, in vitro evaluation, and in silico studiesBioorganic Chemistry, 2022
- New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluationBioorganic Chemistry, 2020
- Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory propertiesEuropean Journal of Medicinal Chemistry, 2019
- Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR explorationEuropean Journal of Medicinal Chemistry, 2018
- A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistryEuropean Journal of Medicinal Chemistry, 2015